ScholarIQanswers from OpenAlex

Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy

PaperCitations, authors & open-access status

Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy have?

ScholarIQcitation count

Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy has 89 citations in the OpenAlex counts ScholarIQ stores.

When was Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy published?

ScholarIQyear

Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy has 2022 year in the ScholarIQ index.

What is the open-access status of Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy?

ScholarIQoa status

Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy has gold oa status in the ScholarIQ index.

What is the DOI of Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy?

ScholarIQdoi

The DOI for Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy is on the source record.

What is the PMID of Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy?

ScholarIQpmid

The PMID for Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy is on the source record.

What is the OpenAlex record for Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy?

ScholarIQopenalex

The OpenAlex for Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial